In an era of increased focus on health and wellness and online sales, Relevium Technologies (TSXV:RLV) (OTC:RLLVF) could be sitting in a perfect position. Through its acquisition of Bioganix and Joint Venture with Hempco for the distribution of its PlanetHemp product line, the company is poised to capture market share in the extremely fast growing hemp and hemp-based derivative market.
Through their successful e-commerce platform and distribution through Amazon, the company has already generated CAD $2.1M in revenue with a gross profit of CAD $1,231,020 (58% gross margin). This has resulted in Relevium already achieving a record month in March for a total of 16,549 units. The recorded units sold for the month of March is anticipated to translate in sales of over CAD $439,000!
With an expertise in online sales and the recent launch of the company’s partnership with Aurora Cannabis backed HempCo products, Relevium is poised to capitalize on the hemp and hemp-based derivative market. Relevium and its cannabis based brands could do quite well in America especially with the Federal government’s recent Hemp Farming Act just introduced. On April 5, 2018 , the company announced it will be expanding its operations to the European market and will include 8 of the company’s best-selling products, mainly through its Amazon channel. These sales are expected to launch during the week of May 21st 2018 and could provide an interesting geographical expansion for hemp products
Furthermore, investors should take notice of a recent appointment of Relevium’s CEO. On Monday April 16, 2018, Linage Grow (CSE: BUDD) announced that Aurelio Useche, CEO of Relevium Technologies, was appointed to Chairman of the Board. This is a very interesting dot to connect with Relevium as Lineage Grow has a seasoned executive team that has been involved with large cannabis companies such as Canopy Growth Corp (TSX: WEED), Tinley (CSE: TNY) (OTC: TNYBF) and Nutritional High (CSE: EAT) (OTC: SPLIF) just to name a few.
Moreover, the company stated in the H2 Guidance on March 2nd 2018 that “Relevium has seen an increase in online content and traffic for hemp and hemp derivatives such as CBD. The market place is changing fast and the rate of adoption as well. In advance of fully launching products, brands and new business segments, the Company has begun accumulating a portfolio of domain names and is also building online assets for an elevated an trusted brand in the space.”
This is a very interesting quote as it indicates to investors that there is a lot more the Company will be delivering on in the coming months within the space.
Therefore we expect that any developments on these fronts could set up Relevium Technologies for a big year especially based on how well-connected the company is at these early stages of a young marijuana industry!
Pursuant to an agreement between Relevium Technologies Inc (RLV), we were hired for a period of 3 months from 4/10/2018 – 7/15/2018 to publicly disseminate information about (RLV) including on the Website and other media including Facebook and Twitter. We are being paid $90,000 (CASH) for or “350,000” shares of restricted or unrestricted common shares. We own zero shares of (RLV) which we purchased in the open market.We may buy or sell additional shares of (RLV) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
